PT2155161T - Composição líquida estável de sulfato de condroitina e glucosamina - Google Patents

Composição líquida estável de sulfato de condroitina e glucosamina

Info

Publication number
PT2155161T
PT2155161T PT87373023T PT08737302T PT2155161T PT 2155161 T PT2155161 T PT 2155161T PT 87373023 T PT87373023 T PT 87373023T PT 08737302 T PT08737302 T PT 08737302T PT 2155161 T PT2155161 T PT 2155161T
Authority
PT
Portugal
Prior art keywords
chondroitinsulfate
glucosamine
liquid composition
stable liquid
stable
Prior art date
Application number
PT87373023T
Other languages
English (en)
Inventor
Pizzoni Angelo
Original Assignee
Apharm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apharm Srl filed Critical Apharm Srl
Publication of PT2155161T publication Critical patent/PT2155161T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT87373023T 2007-06-01 2008-03-14 Composição líquida estável de sulfato de condroitina e glucosamina PT2155161T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001120A ITMI20071120A1 (it) 2007-06-01 2007-06-01 Composizione antiartrosica

Publications (1)

Publication Number Publication Date
PT2155161T true PT2155161T (pt) 2017-03-29

Family

ID=39529878

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87373023T PT2155161T (pt) 2007-06-01 2008-03-14 Composição líquida estável de sulfato de condroitina e glucosamina

Country Status (5)

Country Link
EP (1) EP2155161B1 (pt)
ES (1) ES2619837T3 (pt)
IT (1) ITMI20071120A1 (pt)
PT (1) PT2155161T (pt)
WO (1) WO2008146104A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101926808A (zh) * 2009-06-25 2010-12-29 积华药业有限公司 氨基葡萄糖制剂
US10849923B1 (en) * 2013-10-23 2020-12-01 Donald Wayne Jessup Hyaluronic acid formulation
CN105769802A (zh) * 2014-12-16 2016-07-20 康普药业股份有限公司 一种硫酸软骨素片及其制备方法
CN107375938B (zh) * 2017-08-24 2020-07-07 南京泽恒医药技术开发有限公司 一种盐酸氨基葡萄糖的粘合剂、片剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6416728A (en) * 1987-07-07 1989-01-20 Santen Pharmaceutical Co Ltd Aqueous preparation
US5364845C1 (en) 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
IT1270095B (it) 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US20030069202A1 (en) * 2000-06-02 2003-04-10 Kern Kenneth Norman Compositions, kits, and methods for promoting defined health benefits
US6979458B1 (en) * 2002-09-11 2005-12-27 Kenneth A. Martin Beverage and additive for wellness
JP4947977B2 (ja) * 2003-10-31 2012-06-06 わかもと製薬株式会社 可逆性熱ゲル化水性組成物
US6969706B1 (en) 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins

Also Published As

Publication number Publication date
WO2008146104A2 (en) 2008-12-04
WO2008146104A3 (en) 2009-11-12
EP2155161A2 (en) 2010-02-24
ES2619837T3 (es) 2017-06-27
ITMI20071120A1 (it) 2008-12-02
EP2155161B1 (en) 2016-12-28

Similar Documents

Publication Publication Date Title
IL245172A0 (en) Pharmaceutical preparations and methods for transferring them related to them
PL3110901T3 (pl) Zastosowanie r-1233 w cieczowych urządzeniach chłodzących
GB2469245B (en) Antimicrobial compositions and methods of use thereof
ZA201008713B (en) Antimicrobial compositions and methods of use
ZA201100531B (en) Liquid personal cleansing composition
EP2326171A4 (en) ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
PL2368555T3 (pl) Kompozycje i sposoby stosowania estrów forbolu
EP2276339A4 (en) ANTIMICROBIAL COMPOSITION AND USE
EP2412789A4 (en) LUBRICANT COMPOSITION AND ITS USE
IL209073A0 (en) Liquid cleaning compositions and manufacture
IL211204A0 (en) Mucoadherents compositions and their use
EP2298365A4 (en) MEDICAL COMPOSITION AND MEDICAL KIT
EP2147715A4 (en) STRUCTURE OF AN ONLINE MIXER
EP2184063A4 (en) USE OF LEONURINE AND COMPOSITIONS THEREOF
PT2155161T (pt) Composição líquida estável de sulfato de condroitina e glucosamina
ZA201004894B (en) Nuctraceutical composition and methods of use
PL2076243T3 (pl) Płynna formulacja G-CSF
HK1155062A1 (en) Pharmaceutical composition and combined agent
ZA201004893B (en) Nuctraceutical composition and methods of use
GB0617923D0 (en) Improvements in and relating to the storage and delivery of liquids
GB2461611B (en) Composition and use thereof
ZA200807154B (en) Liquid treatment composition
GB0810409D0 (en) Composition and use thereof
GB0808877D0 (en) Composition and use thereof
GB0805492D0 (en) Improvements in or relating to the delivery of contrast agents